Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
30 participants
INTERVENTIONAL
2022-07-15
2024-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Endovascular vs Surgical Arteriovenous Fistula Outcomes
NCT04404985
Ultrasound Prediction of Successful Balloon Assisted AVF Maturation
NCT06771973
FLEX Vessel Prep Prior to Angioplasty in Native Arteriovenous Fistulae (AVF)
NCT05034939
Arterio-Venous Fistula Audit. Successful Utilisation Rates of Arterio-Venous Fistulae for Haemodialysis at University Hospital Limerick
NCT05801549
Clinical and Mechanistic Research on Autogenous Arteriovenous Fistula in Hemodialysis Patients
NCT07058441
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SEQUENTIAL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Alucent VRS for Treatment of Atherosclerotic Lesions
Alucent Vessel Restoration System for AVF (VRS-AVF) consists of the following components:
1. VRS 10-8-10 Dimer Coated Balloon Catheter for AVF
2. VRS Light Fiber
3. VRS Light Source
Alucent Vessel Restoration System for AVF
Alucent Vessel Restoration System for AVF (VRS-AVF) consists of the following components:
1. VRS 10-8-10 Dimer Coated Balloon Catheter for AVF
2. VRS Light Fiber
3. VRS Light Source
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Alucent Vessel Restoration System for AVF
Alucent Vessel Restoration System for AVF (VRS-AVF) consists of the following components:
1. VRS 10-8-10 Dimer Coated Balloon Catheter for AVF
2. VRS Light Fiber
3. VRS Light Source
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Use birth control
* Chronic Kidney Disease
Exclusion Criteria
* Pregnant, breastfeeding, planning to become pregnant
* Receiving immunosuppressants
* Has "Long COVID"
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alucent Biomedical
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia
Prince of Wales
Randwick, New South Wales, Australia
Royal North Shore Hospital & North Shore Private
Saint Leonards, New South Wales, Australia
Royal Adelaide Hospital
Adelaide, South Australia, Australia
Flinders Medical Center
Bedford Park, South Australia, Australia
The Alfred Hospital
Melbourne, Victoria, Australia
Northern Health
Richmond, Victoria, Australia
Royal Perth Hospital
Perth, Western Australia, Australia
Poznan University of Medical Sciences
Lublin, , Poland
Wojskowy Instytut Medczny z Centrainym Szpitalem Klinicznym Ministerstwa Obrony Narodowej
Warsaw, , Poland
Lower Silesia Center of Heart Diseases MEDINet
Wroclaw, , Poland
Klincznny Oddzial Chirurgii Naczyniowej Szpital Uniweryzstecki w Zielonej
Zielona Góra, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1061-003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.